<\/p>\n
The European Business Association warns that the proposed amendments to Draft Law No. 13420 could deprive Ukrainians of access to many essential medicines and disrupt the operation of state pharmaceutical supply programmes.<\/p>\n
According to information received in the course of work, the amendments were submitted to the Verkhovna Rada Committee on Finance, Taxation and Customs Policy as part of work on the Draft Law of Ukraine \u201cOn Amendments to the Tax Code of Ukraine and Other Laws of Ukraine Regarding Support for Enterprises of the Defence Industry\u201d No. 13420 of 25 June 2025.<\/p>\n
In particular, it is proposed to amend Part 14 of Article 9-1 and Part 2 of Article 17 of the Law of Ukraine \u201cOn Medicinal Products\u201d No. 123\/96-VR of 4 April 1996.<\/p>\n
First and foremost, it should be noted that the essence of the proposed amendment does not correspond to the purpose of the draft law, as it envisages regulating the medicinal products market rather than supporting defence industry enterprises. Given its significant impact on Ukraine\u2019s healthcare system, EBA representatives believe that any changes to Law No. 123\/96-VR should be considered within the profile Verkhovna Rada Committee on National Health, Medical Care and Medical Insurance.<\/p>\n
Key risks:<\/strong><\/p>\n The combination of these changes poses a real threat of supply disruptions, price increases, reduced competition, and lower interest from international manufacturers in operating in Ukraine. For patients, this means the risk of interrupted treatment; for the state, it weakens the resilience of the healthcare system during wartime.<\/p>\n The European Business Association calls on MPs not to support these amendments and to consider any legislative changes in the healthcare sector only after discussion within the relevant parliamentary committee.<\/p>\n <\/p>","protected":false},"excerpt":{"rendered":" The European Business Association warns that the proposed amendments to Draft Law No. 13420 could deprive Ukrainians of access to many essential medicines and disrupt the operation of state pharmaceutical supply programmes. According to information received in the course of work, the amendments were submitted to the Verkhovna Rada Committee on Finance, Taxation and Customs […]<\/p>\n","protected":false},"author":33544,"featured_media":662750,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[4,5,22],"tags":[],"yoast_head":"\n\n